International Journal of Antimicrobial Agents

Aims & Scope

The International Journal of Antimicrobial Agents provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents (antiviral agents, antiparasitic agents, antibacterial agents, antifungal agents, etc.).

In addition, the journal signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents.

Special attention is given to articles providing insight into the problems of antimicrobial resistance both in the hospital and in the community.

Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.6
2024	4.90

Journal Citation Indicator

Year	Value
2024	2627

SJR (SCImago Journal Rank)

Year	Value
2024	0.955

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	161

Journal Rank

Year	Value
2024	5222

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

  Citation: 4051

  Authors: Chih-Cheng, Tzu-Ping, Wen-Chien, Hung-Jen, Po-Ren

• RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

  Citation: 3330

  Authors: Philippe, Jean-Christophe, Philippe, Van Thuan, Line, Morgane, Barbara, Johan, Valérie, Vera Esteves, Hervé, Stéphane, Philippe, Eric, Bernard, Jean-Marc, Philippe, Didier

• Antimicrobial activity of flavonoids

  Citation: 2868

  Authors: T.P. Tim, Andrew J.

• Antibiotic resistance of bacterial biofilms

  Citation: 2587

  Authors: Niels, Thomas, Michael, Søren, Oana

• Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

  Citation: 1371

  Authors: Chi, Zhao, Jia-Wen, Hong, Gui-Qiang

• Characterisation of copper oxide nanoparticles for antimicrobial applications

  Citation: 1304

  Authors: Guogang, Dawei, Eileen W.C., Miguel A., Paul, Robert P.

• Recent advances in understanding the antibacterial properties of flavonoids

  Citation: 911

  Authors: T.P. Tim, Andrew J.

• Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

  Citation: 870

  Authors: N, M, J, J, M, S, S, D

• Antimicrobial peptides: premises and promises

  Citation: 828

  Authors: K.V.R., R.D., C.

• Coronavirus disease 2019 (COVID-19): current status and future perspectives

  Citation: 775

  Authors: Heng, Shang-Ming, Xiao-Hua, Shi-Lin, Chao-Ke

---